GlyCardial Diagnostics, a CataloniaBio & HealthTech member, has announced the appointment of Juan Carlos Kaski as Chief Medical Officer (CMO).
Juan Carlos Kaski is a professor of Cardiovascular Science and the Immediate-Past Director of the Cardiovascular and Cell Sciences Research Institute at St George’s (University of London). He is also an honorary consultant cardiologist at St George’s Hospital and the Royal Brompton Hospital in London.
He has authored over 650 papers and book chapters, eight books and the most recent edition of the European Society of Cardiology Handbook of Cardiovascular Pharmacotherapy. He is editor-in-chief of the European Cardiology Review and an editorial board member of over 20 major cardiology journals.
GlyCardial is focused on developing a novel in vitro diagnostic device for myocardial ischaemia. The technology is based on detecting Apo J-Glyc in blood as a biomarker for early diagnosis and prediction of a patient’s evolution after an ischaemic event. Currently, the company, based at the Barcelona Science Park, is doing a multicentre international in vitro study (2019-2021) to validate the performance of Apo J-Glyc.
Comments